To: The Ox who wrote (29932 ) 4/12/2006 7:20:36 PM From: Donald Wennerstrom Read Replies (2) | Respond to of 95427 FWIW, here is what CSFB had to say about LRCX yesterday prior to the earnings release and conference call. CSFB has an "outperform" rating on LRCX. <<F3Q (Mar) preview. LRCX will kick-off earnings season for semi-cap companies, reporting F3Q (Mar) results post the close of markets Wed, Apr 12; CC at 5PM EST, dial-in 303.262.2193. We are modeling rev/EPS of $430mm and 63c; consensus is at $424mm and 62c; guidance was $410-$430mm and 57-63c; all estimates include option expense. We expect company to report March orders at mid-point of guidance of 25-30% q/q growth, at ~$515mm; and March shipments inline with guidance at $510mm (up 30% q/q). We expect order exposure to memory to decline from ~80% in Dec to ~50% in March; expect foundries to drive the March order growth. F4Q (Jun) expectations. We are currently modeling Jun rev/EPS at $500mm and 81c, versus consensus at $467mm and 72c; our estimates are well above consensus, but are consistent with Lam’s strong shipment trends in March, and continued bookings strength into June. Although LRCX’s March order growth of up 25-30% q/q will be above SCE average at up 15-20%, we expect LRCX to guide June orders in line with the rest of the group, at up 5-10% q/q; we think order composition by device should remain more or less unchanged q/q. A relative out-performer. Our longer-term positive outlook on LRCX is based upon (i) Cheap valuation – stock trading at an 18% discount to peers on ’06 EPS; (ii) Franchise value – Lam’s share gains (see charts) will stick longer due to higher switching costs for etch; and (iii) Growth potential – among large cap SCE, LRCX has most potential to outgrow by expanding into new markets . Outlook – pay for a Marathon, not a Sprint. In addition to these fundamental positives, there is upside to consensus for March and June as well – that said expect the war cry from bears after the call to be “what else can LRCX do for an encore?” From a purely momentum perspective, there is not much – we think September orders/shipments WILL decline for LRCX (along with everyone else in the group, see model) . Of course momentum is important, but in the case of Lam, obsessing on this one metric overlooks: (i) rather substantial longer-term positives for the company, and (ii) a secular trend of lower peak to trough declines for group. Would still recommend longer-term oriented investors accumulate shares if stock were to show any weakness post earnings. >>